Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-08-01

AUTHORS

MJ Humphreys, P Ghaneh, W Greenhalf, F Campbell, TM Clayton, P Everett, BE Huber, CA Richards, MJ Ford, JP Neoptolemos

ABSTRACT

Targeting of colorectal liver metastases by regional gene therapy was tested in a clinically relevant syngeneic model. First, the CEA-CD-113 retroviral vector containing the cytosine deaminase gene controlled by the CEA specific tumour cell promoter, was shown in vitro to convert 5-fluorocytosine to 5-fluorouracil, resulting in cancer cell killing with a large bystander effect. Second, 10 days after the establishment of liver metastases, retroviral vectors were delivered to the liver by hepatic artery injection. After 5-fluorocytosine administration for 7 days, most surface metastases disappeared and tumour volumes were suppressed up to 8.2-fold. The results support the development of this approach for patient treatment. More... »

PAGES

1241-1247

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.gt.3301518

DOI

http://dx.doi.org/10.1038/sj.gt.3301518

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001388877

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11509957


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoembryonic Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colonic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytosine Deaminase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flucytosine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intra-Arterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intraperitoneal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleoside Deaminases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Promoter Regions, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retroviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Surgery, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Humphreys", 
        "givenName": "MJ", 
        "id": "sg:person.014034161712.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014034161712.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Surgery, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "P", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Surgery, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Greenhalf", 
        "givenName": "W", 
        "id": "sg:person.01116776343.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Pathology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "F", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UK GlaxoSmithKline Inc., Beckenham, Kent, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "UK GlaxoSmithKline Inc., Beckenham, Kent, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clayton", 
        "givenName": "TM", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UK GlaxoSmithKline Inc., Beckenham, Kent, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "UK GlaxoSmithKline Inc., Beckenham, Kent, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Everett", 
        "givenName": "P", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline Inc., Research Triangle Park, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline Inc., Research Triangle Park, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huber", 
        "givenName": "BE", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline Inc., Research Triangle Park, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline Inc., Research Triangle Park, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Richards", 
        "givenName": "CA", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline Inc., Stevenage, Hertfordshire, UK", 
          "id": "http://www.grid.ac/institutes/grid.418236.a", 
          "name": [
            "GlaxoSmithKline Inc., Stevenage, Hertfordshire, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ford", 
        "givenName": "MJ", 
        "id": "sg:person.0774574537.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774574537.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Surgery, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "JP", 
        "id": "sg:person.0750565077.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.cgt.7700131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030407045", 
          "https://doi.org/10.1038/sj.cgt.7700131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.1999.1254", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044768203", 
          "https://doi.org/10.1054/bjoc.1999.1254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3300637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014297031", 
          "https://doi.org/10.1038/sj.gt.3300637"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-08-01", 
    "datePublishedReg": "2001-08-01", 
    "description": "Targeting of colorectal liver metastases by regional gene therapy was tested in a clinically relevant syngeneic model. First, the CEA-CD-113 retroviral vector containing the cytosine deaminase gene controlled by the CEA specific tumour cell promoter, was shown in vitro to convert 5-fluorocytosine to 5-fluorouracil, resulting in cancer cell killing with a large bystander effect. Second, 10 days after the establishment of liver metastases, retroviral vectors were delivered to the liver by hepatic artery injection. After 5-fluorocytosine administration for 7 days, most surface metastases disappeared and tumour volumes were suppressed up to 8.2-fold. The results support the development of this approach for patient treatment.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.gt.3301518", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "16", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "colorectal liver metastases", 
      "liver metastases", 
      "cytosine deaminase gene", 
      "hepatic artery injection", 
      "intra-arterial delivery", 
      "large bystander effect", 
      "retroviral vectors", 
      "intraperitoneal treatment", 
      "surface metastases", 
      "artery injection", 
      "syngeneic model", 
      "tumor volume", 
      "metastasis", 
      "patient treatment", 
      "CEA promoter", 
      "cancer cells", 
      "suppress growth", 
      "deaminase gene", 
      "bystander effect", 
      "gene therapy", 
      "treatment", 
      "days", 
      "therapy", 
      "liver", 
      "administration", 
      "regional gene therapy", 
      "injection", 
      "genes", 
      "delivery", 
      "cells", 
      "promoter", 
      "effect", 
      "volume", 
      "development", 
      "vector", 
      "results", 
      "growth", 
      "establishment", 
      "model", 
      "approach"
    ], 
    "name": "Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases", 
    "pagination": "1241-1247", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001388877"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.gt.3301518"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11509957"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.gt.3301518", 
      "https://app.dimensions.ai/details/publication/pub.1001388877"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_315.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.gt.3301518"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301518'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301518'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301518'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301518'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      89 URIs      78 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.gt.3301518 schema:about N036628bf4f4c4b3f8fca94e174dd1528
2 N1770328bead245a397f3e4ec7f4469be
3 N1a2bf431adf34546afacafb2e7a6fb66
4 N214db48f087645fca94cd3cc711fb4e8
5 N26798514cef541ba89a05ee879b0d80d
6 N57d3fbc2668e4906b57df61f6ce8f068
7 N62740a9bba2a426781cbd0fc6824887e
8 N698c16c07b0b48d3a8579d73149d9bc9
9 N7359c50b03b9426f9af047be7d27809c
10 N810ffc6da7fa4810a64ee376ffb35627
11 N8bae49e8118748ac9d427e8ef1f3c9c3
12 N93448bc398e245c79efd173c0cca533a
13 N9618cf2ac74f442686a97309a5a4c6f3
14 N9942ab35a5d549899a6add0a483913b3
15 Na2efe2d1f22c4204acae5fab2d892b8d
16 Nbe263973c90449eab5867352ec083fd1
17 Nbecb4b1f264d4d6eaa0e2347d7d5e689
18 Nd604f3b7e59c43888787e3ec613237cf
19 Nd63ef7264d0d434cbebf51a00704f20b
20 Ne436997236144cfb8df43be138e470a1
21 Nf334e7c3d472479a97ed71861bc4e21a
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N3af52d6aec384989a60dfc02d9f333c0
25 schema:citation sg:pub.10.1038/sj.cgt.7700131
26 sg:pub.10.1038/sj.gt.3300637
27 sg:pub.10.1054/bjoc.1999.1254
28 schema:datePublished 2001-08-01
29 schema:datePublishedReg 2001-08-01
30 schema:description Targeting of colorectal liver metastases by regional gene therapy was tested in a clinically relevant syngeneic model. First, the CEA-CD-113 retroviral vector containing the cytosine deaminase gene controlled by the CEA specific tumour cell promoter, was shown in vitro to convert 5-fluorocytosine to 5-fluorouracil, resulting in cancer cell killing with a large bystander effect. Second, 10 days after the establishment of liver metastases, retroviral vectors were delivered to the liver by hepatic artery injection. After 5-fluorocytosine administration for 7 days, most surface metastases disappeared and tumour volumes were suppressed up to 8.2-fold. The results support the development of this approach for patient treatment.
31 schema:genre article
32 schema:isAccessibleForFree false
33 schema:isPartOf Na3a66c2eff3e4c558a441fcb10b7fd52
34 Nf37155747cfe4a9ca817061a84a9be2d
35 sg:journal.1105638
36 schema:keywords CEA promoter
37 administration
38 approach
39 artery injection
40 bystander effect
41 cancer cells
42 cells
43 colorectal liver metastases
44 cytosine deaminase gene
45 days
46 deaminase gene
47 delivery
48 development
49 effect
50 establishment
51 gene therapy
52 genes
53 growth
54 hepatic artery injection
55 injection
56 intra-arterial delivery
57 intraperitoneal treatment
58 large bystander effect
59 liver
60 liver metastases
61 metastasis
62 model
63 patient treatment
64 promoter
65 regional gene therapy
66 results
67 retroviral vectors
68 suppress growth
69 surface metastases
70 syngeneic model
71 therapy
72 treatment
73 tumor volume
74 vector
75 volume
76 schema:name Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases
77 schema:pagination 1241-1247
78 schema:productId N01629087ceb24946a0897c357c6537ac
79 N3b957c75605049cc998aa1dcf199a08f
80 N9cecf5e85eab425ea070393f4e90c71c
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001388877
82 https://doi.org/10.1038/sj.gt.3301518
83 schema:sdDatePublished 2022-09-02T15:48
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Nbb933663b2234ccd84c1cb9225dae157
86 schema:url https://doi.org/10.1038/sj.gt.3301518
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N01629087ceb24946a0897c357c6537ac schema:name dimensions_id
91 schema:value pub.1001388877
92 rdf:type schema:PropertyValue
93 N036628bf4f4c4b3f8fca94e174dd1528 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Rats
95 rdf:type schema:DefinedTerm
96 N134f32fb692444579ea12c0685fee2dd rdf:first sg:person.0646035141.16
97 rdf:rest Nb5a4755104b041bdb9d8ae21d51b8a4c
98 N164251bb4ec34f01845f6ff3e5471d27 rdf:first sg:person.0774574537.66
99 rdf:rest N27d8e67aaad0443ebe975b40f9f5cb22
100 N1770328bead245a397f3e4ec7f4469be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Cytosine Deaminase
102 rdf:type schema:DefinedTerm
103 N1a2bf431adf34546afacafb2e7a6fb66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Liver Neoplasms
105 rdf:type schema:DefinedTerm
106 N214db48f087645fca94cd3cc711fb4e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Carcinoembryonic Antigen
108 rdf:type schema:DefinedTerm
109 N26798514cef541ba89a05ee879b0d80d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Animals
111 rdf:type schema:DefinedTerm
112 N27d8e67aaad0443ebe975b40f9f5cb22 rdf:first sg:person.0750565077.18
113 rdf:rest rdf:nil
114 N2fe3bd290ff8410fb66091d8697a1534 schema:affiliation grid-institutes:grid.418019.5
115 schema:familyName Richards
116 schema:givenName CA
117 rdf:type schema:Person
118 N3af52d6aec384989a60dfc02d9f333c0 rdf:first sg:person.014034161712.89
119 rdf:rest Nc14f6ab72d0b4cacaa66cc2a789e1391
120 N3b957c75605049cc998aa1dcf199a08f schema:name doi
121 schema:value 10.1038/sj.gt.3301518
122 rdf:type schema:PropertyValue
123 N57d3fbc2668e4906b57df61f6ce8f068 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Male
125 rdf:type schema:DefinedTerm
126 N62740a9bba2a426781cbd0fc6824887e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Models, Animal
128 rdf:type schema:DefinedTerm
129 N698c16c07b0b48d3a8579d73149d9bc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Injections, Intra-Arterial
131 rdf:type schema:DefinedTerm
132 N7359c50b03b9426f9af047be7d27809c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Nucleoside Deaminases
134 rdf:type schema:DefinedTerm
135 N810ffc6da7fa4810a64ee376ffb35627 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Carcinoma
137 rdf:type schema:DefinedTerm
138 N8bae49e8118748ac9d427e8ef1f3c9c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Antimetabolites
140 rdf:type schema:DefinedTerm
141 N92774348b9b84f53a23040346c9b233f rdf:first N2fe3bd290ff8410fb66091d8697a1534
142 rdf:rest N164251bb4ec34f01845f6ff3e5471d27
143 N93448bc398e245c79efd173c0cca533a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Flucytosine
145 rdf:type schema:DefinedTerm
146 N9618cf2ac74f442686a97309a5a4c6f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Colonic Neoplasms
148 rdf:type schema:DefinedTerm
149 N9942ab35a5d549899a6add0a483913b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Genetic Vectors
151 rdf:type schema:DefinedTerm
152 N9cecf5e85eab425ea070393f4e90c71c schema:name pubmed_id
153 schema:value 11509957
154 rdf:type schema:PropertyValue
155 Na2efe2d1f22c4204acae5fab2d892b8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Promoter Regions, Genetic
157 rdf:type schema:DefinedTerm
158 Na3a66c2eff3e4c558a441fcb10b7fd52 schema:volumeNumber 8
159 rdf:type schema:PublicationVolume
160 Na73a6db5e2b74d1183ad761c10da56c4 rdf:first Nad04cb4784f84680b6861b4e6d60482a
161 rdf:rest Nd8999fc508ab454893b8e1b2d756abfd
162 Nad04cb4784f84680b6861b4e6d60482a schema:affiliation grid-institutes:None
163 schema:familyName Everett
164 schema:givenName P
165 rdf:type schema:Person
166 Nb5a4755104b041bdb9d8ae21d51b8a4c rdf:first Ne41f631cd94b47a2986a2a48d3a0ca83
167 rdf:rest Na73a6db5e2b74d1183ad761c10da56c4
168 Nbb933663b2234ccd84c1cb9225dae157 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 Nbe263973c90449eab5867352ec083fd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Genetic Therapy
172 rdf:type schema:DefinedTerm
173 Nbecb4b1f264d4d6eaa0e2347d7d5e689 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Hepatic Artery
175 rdf:type schema:DefinedTerm
176 Nc08c6a46a7bf47d69d0878a009e74fbb rdf:first sg:person.01116776343.06
177 rdf:rest N134f32fb692444579ea12c0685fee2dd
178 Nc14f6ab72d0b4cacaa66cc2a789e1391 rdf:first sg:person.07372440237.86
179 rdf:rest Nc08c6a46a7bf47d69d0878a009e74fbb
180 Nd604f3b7e59c43888787e3ec613237cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Tumor Cells, Cultured
182 rdf:type schema:DefinedTerm
183 Nd63ef7264d0d434cbebf51a00704f20b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Retroviridae
185 rdf:type schema:DefinedTerm
186 Nd8999fc508ab454893b8e1b2d756abfd rdf:first Nf417cd25e6174ceaa0d0fda12a30c417
187 rdf:rest N92774348b9b84f53a23040346c9b233f
188 Ne41f631cd94b47a2986a2a48d3a0ca83 schema:affiliation grid-institutes:None
189 schema:familyName Clayton
190 schema:givenName TM
191 rdf:type schema:Person
192 Ne436997236144cfb8df43be138e470a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Neoplasm Transplantation
194 rdf:type schema:DefinedTerm
195 Nf334e7c3d472479a97ed71861bc4e21a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Injections, Intraperitoneal
197 rdf:type schema:DefinedTerm
198 Nf37155747cfe4a9ca817061a84a9be2d schema:issueNumber 16
199 rdf:type schema:PublicationIssue
200 Nf417cd25e6174ceaa0d0fda12a30c417 schema:affiliation grid-institutes:grid.418019.5
201 schema:familyName Huber
202 schema:givenName BE
203 rdf:type schema:Person
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
208 schema:name Oncology and Carcinogenesis
209 rdf:type schema:DefinedTerm
210 sg:journal.1105638 schema:issn 0969-7128
211 1476-5462
212 schema:name Gene Therapy
213 schema:publisher Springer Nature
214 rdf:type schema:Periodical
215 sg:person.01116776343.06 schema:affiliation grid-institutes:grid.10025.36
216 schema:familyName Greenhalf
217 schema:givenName W
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06
219 rdf:type schema:Person
220 sg:person.014034161712.89 schema:affiliation grid-institutes:grid.10025.36
221 schema:familyName Humphreys
222 schema:givenName MJ
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014034161712.89
224 rdf:type schema:Person
225 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.10025.36
226 schema:familyName Campbell
227 schema:givenName F
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
229 rdf:type schema:Person
230 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.10025.36
231 schema:familyName Ghaneh
232 schema:givenName P
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
234 rdf:type schema:Person
235 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.10025.36
236 schema:familyName Neoptolemos
237 schema:givenName JP
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
239 rdf:type schema:Person
240 sg:person.0774574537.66 schema:affiliation grid-institutes:grid.418236.a
241 schema:familyName Ford
242 schema:givenName MJ
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774574537.66
244 rdf:type schema:Person
245 sg:pub.10.1038/sj.cgt.7700131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030407045
246 https://doi.org/10.1038/sj.cgt.7700131
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/sj.gt.3300637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014297031
249 https://doi.org/10.1038/sj.gt.3300637
250 rdf:type schema:CreativeWork
251 sg:pub.10.1054/bjoc.1999.1254 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044768203
252 https://doi.org/10.1054/bjoc.1999.1254
253 rdf:type schema:CreativeWork
254 grid-institutes:None schema:alternateName UK GlaxoSmithKline Inc., Beckenham, Kent, UK
255 schema:name UK GlaxoSmithKline Inc., Beckenham, Kent, UK
256 rdf:type schema:Organization
257 grid-institutes:grid.10025.36 schema:alternateName Department of Pathology, University of Liverpool, Liverpool, UK
258 Department of Surgery, University of Liverpool, Liverpool, UK
259 schema:name Department of Pathology, University of Liverpool, Liverpool, UK
260 Department of Surgery, University of Liverpool, Liverpool, UK
261 rdf:type schema:Organization
262 grid-institutes:grid.418019.5 schema:alternateName GlaxoSmithKline Inc., Research Triangle Park, NC, USA
263 schema:name GlaxoSmithKline Inc., Research Triangle Park, NC, USA
264 rdf:type schema:Organization
265 grid-institutes:grid.418236.a schema:alternateName GlaxoSmithKline Inc., Stevenage, Hertfordshire, UK
266 schema:name GlaxoSmithKline Inc., Stevenage, Hertfordshire, UK
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...